UAE Pharmaceutical Market, By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribu

UAE Pharmaceutical Market, By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2027

UAE pharmaceutical market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of expanding healthcare industry and investment in the industry. Surging demands from the growing population of the country for efficient pharmaceutical products are further driving the growth of the UAE pharmaceutical market in the upcoming five years.

Government Initiatives Drive Market Growth

United Arab Emirates’ government is actively focused on advancing the pharmaceutical industry. Initiatives like the Dubai Industrial Strategy 2030 and the Abu Dhabi vision 2030 is focused toward developing the pharmaceutical industry due to its future growth prospects, export potential and mid-term to long-term economic impact. Till recent past, the country pharmaceutical demands were highly met through imported drugs and pharmaceutical products. Going forward, the country is actively functioning to decrease the import of pharmaceutical and manufacture their own products through increasing investments in pharmaceutical and therapeutic products’ research and development.

In the year 2018, country imported pharmaceutical products worth over USD14.9 billion from the countries like Germany, USA, France and Switzerland. To increase their self-production of pharmaceutical products the country is initiating bonds with multinational market players. With favorable schemes and plans for the distribution channels and funding strategic location and sophisticated logistics infrastructure is also anticipated to further strengthen the growth of the UAE pharmaceutical market in the future five years.

India – UAE Bilateral Trade Supports Pharmaceutical Industry

India stands 3rd in terms of pharmaceutical products volume production and 14th in terms of value of the industry across the world. With the historic partnership, the countries are trying to establish a conjugated pharmaceutical industry that would benefit the industry in both countries. Moreover, with the recent pandemic effect the import-export channels have suffered drastically in recent years. Therefore, UAE is trying to establish more permanent solution to the surging demands for the pharmaceutical products in the country.

Growing Instances Of Diseases Upsurges Drug Demands

Increasing number of chronic diseases, infectious diseases, and lifestyle diseases are major factor influencing the growth of the pharmaceutical market in the country. Chronic diseases like cardiovascular diseases, cancer, neurological disorders, etc. are driving the market growth. 4,807 new cancer cases were observed in the country among both male and female population in the country.

Infectious diseases due to higher tourism, and environmental factor, and the recent viral infection due to COVID-19 facilitated the demand for pharmaceutical products. Disrupted import channels, have pushed the pharmaceutical companies in the country to manufacture drugs and medicines in the country and government also supported the notion with higher investment in the sector.

Market Segmentation

The UAE pharmaceutical market is segmented by drug type, product type, application, distribution channel, competitional landscape, and regional distribution. Based on drug type, the market is differentiated between generic drugs and branded drugs. Product type based market segment is divided between prescription drugs and over the counter drugs. Application based market segment is further fragmented into cardiovascular, musculoskeletal, oncology, anti-infective, metabolic disorder, and others. Based on distribution channel, the market is bifurcated into retail pharmacy, hospital pharmacy, and e-pharmacy. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Dubai region, Sharjah region, Abu Dhabi region and the rest of the UAE.

Company Profile

Julphar Gulf Pharmaceutical Industries, Bayer Consumer Health, Lifepharma FZE, Niner Pharmaceuticals LLC, GlaxoSmithKline & Neopharma, Pfizer UAE, Johnson & Johnson Middle East FZ-LLC, among others is a partial list of major market players of the companies responsible for the growth of UAE pharmaceutical market.

Report Scope:

In this report, UAE pharmaceutical market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • UAE Pharmaceutical Market, By Drug Type:
  • Generic Drugs
  • Branded Drugs
  • UAE Pharmaceutical Market, By Product Type:
  • Prescription Drugs
  • Over-The-Counter Drugs
  • UAE Pharmaceutical Market, By Application:
  • Cardiovascular
  • Musculoskeletal
  • Oncology
  • Anti-infective
  • Metabolic Disorder
  • Others
  • UAE Pharmaceutical Market, By Distribution Channel:
  • Retail Pharmacy
  • Hospital Pharmacy
  • E-Pharmacy
  • UAE Pharmaceutical Market, By Region:
  • Dubai Region
  • Sharjah Region
  • Abu Dhabi Region
  • Rest of UAE
Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in UAE pharmaceutical market.

Company Information
  • Detailed analysis and profiling of additional market players (up to five).
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on UAE Pharmaceutical Market
4. Executive Summary
5. Voice of Customer
6. UAE Pharmaceutical Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)
6.2.2. By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)
6.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)
6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. UAE Generic Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Application
7.2.3. By Distribution Channel
8. UAE Branded Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Application
8.2.3. By Distribution Channel
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
11. Policy & Regulatory Landscape
12. UAE Economic Profile
13. Competitive Landscape
13.1. Competition Outlook
13.2. Company Profiles
13.2.1. Julphar Gulf Pharmaceutical Industries
13.2.2. Bayer Consumer Health
13.2.3. Lifepharma FZE
13.2.4. Niner Pharmaceuticals LLC
13.2.5. GlaxoSmithKline & Neopharma
13.2.6. Pfizer UAE
13.2.7. Johnson & Johnson Middle East FZ-LLC
14. Strategic Recommendations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings